OMM, HSF advise on Chinese pharma firm’s $461 mln HK IPO

BY Aparna Sai |

O'Melveny & Myers, Tian Yuan Law Firm and William Ji & Co. have represented China’s Simcere Pharmaceutical Group on its HK$3.57 billion ($460.6 million) Hong Kong IPO, with Herbert Smith Freehills and Jingtian & Gongcheng advising the joint sponsors.

Asia Deals: Week of October 26

BY Rowena Muñiz |

A&O and Linklaters on PRC’s $6 bln bonds offering, CAM and Khaitan on Brookfield’s $2 bln acquisition of RMZ Corp portfolio, and much more in this week’s Asia Deals roundup.

Kim & Chang, Skadden, BKL on Korea’s largest-ever domestic M&A

BY Aparna Sai |

Kim & Chang and Skadden, Arps, Slate, Meagher & Flom have represented South Korea’s SK Hynix on its $9 billion acquisition of U.S.

Gibson Dunn advises Kimberly-Clark on $1.2 bln Indonesia acquisition

BY Aparna Sai |

Gibson Dunn & Crutcher has advised U.S. consumer products company Kimberly-Clark Corporation on its $1.2 billion acquisition of personal care maker Softex Indonesia, which was represented by Singapore’s Allen & Gledhill and Soemadipradja & Taher.

Skadden, Latham advise on $6 bln merger of Chinese live game streaming firms Huya, DouYu

BY Aparna Sai |

Skadden, Arps, Slate, Meagher & Flom has advised China’s Huya on agreement to buy live game streaming peer DouYu International. Latham & Watkins has represented Tencent, which is Huya’s biggest shareholder and also owns more than a third of DouYu.

Paul Hastings, Dentons, Freshies, KWM act on Weihai Bank’s $365 mln HK IPO

BY Aparna Sai |

Paul Hastings and Dentons have advised China’s Weihai City Commercial Bank on its $365.3 million IPO on the Hong Kong Stock Exchange, with Freshfields Bruckhaus Deringer and King & Wood Mallesons advising the joint sponsors and the underwriters.

Skadden, Kirkland advise on Chinese biotech firm’s $451 million HK IPO

BY Aparna Sai |

Skadden, Arps, Slate, Meagher & Flom and Zhong Lun Law Firm have advised China’s Everest Medicines on its $451 million IPO in Hong Kong, with Kirkland & Ellis and Tian Yuan Law Firm advising the joint sponsors and underwriters.

Asia Deals: Week of October 12

BY Rowena Muñiz |

Latham and Skadden on $6 bln game streaming firms’ merger, Nishimura on Blackstone’s $2.3 bln pharma acquisition, and much more in this week’s Asia Deals roundup

Davis Polk, CAM advise India’s Reliance on sale of $2.6 bln of stakes in retail unit

BY Aparna Sai |

Davis Polk & Wardwell and Cyril Amarchand Mangaldas have advised Reliance Industries on its $2.6 billion sale of stakes in its retail unit to Singapore sovereign wealth fund GIC, global private equity firm TPG Capital, Abu Dhabi Investment Authority (ADIA) and Mubadala Investment Company.

Skadden, Kirkland act on Chinese biopharma firm’s $371 mln HK IPO

BY Aparna Sai |

Skadden, Arps, Slate, Meagher & Flom has advised Shanghai-based biopharmaceutical company JHBP (CY) Holdings, a holding company for Genor Biopharma,  on its HK $2.87 billion ($371 million) IPO in Hong Kong, with Kirkland & Ellis representing the joint sponsors and the underwriters.

Asia Deals: Week of October 5

BY Rowena Muñiz |

JSA on DXC Technology's $5 bln deal with Veritas, host of firms on Offshore Bridge Facility's $1.75 billion take-private, and much more in this week's Asia Deals roundup.

Orrick advises as Japan’s NTT takes mobile unit Docomo private

BY Aparna Sai |

U.S. law firm Orrick, Herrington & Sutcliffe has advised Japan's largest mobile phone operator Docomo, publicly listed some 28 years ago, on a 4.25 trillion yen ($40 billion) tender offer by its parent company NTT to take it private.